Mahfouz A E, Hamm B, Mathieu D
Department of Radiology, Hôpital Henri Mondor, Créteil, France.
Eur Radiol. 1996;6(5):607-14. doi: 10.1007/BF00187658.
Metastatic disease to the liver is an important disease from the diagnostic, prognostic and therapeutic points of view. Different imaging modalities, such as US, CT, scintigraphy, and MRI, have been used for detection, characterization, therapy planning, and follow-up of this disease with variable degrees of success and failure. This review handles the problems which face the different imaging modalities in diagnosis of liver metastases in view of the pathological background of the disease. It also discusses the indications, strong points, and shortcomings of each of the imaging modalities in diagnosis of metastases, and surveys the recent efforts done to improve their performance through the optimization of quality control and in the innovations in the field of contrast agents. Finally, a protocol is suggested for the clinical management of patients with liver metastases to optimize cost-effectiveness of the imaging modalities in this era of multimodality approach in diagnostic imaging.
从诊断、预后和治疗的角度来看，肝脏转移性疾病是一种重要的疾病。不同的成像方式，如超声（US）、计算机断层扫描（CT）、闪烁扫描和磁共振成像（MRI），已被用于该疾病的检测、特征描述、治疗规划和随访，但取得的成功程度和失败程度各不相同。鉴于该疾病的病理背景，本综述探讨了不同成像方式在诊断肝转移瘤时面临的问题。它还讨论了每种成像方式在转移瘤诊断中的适应症、优点和缺点，并调查了最近通过优化质量控制和造影剂领域的创新来提高其性能所做的努力。最后，提出了一个针对肝转移瘤患者的临床管理方案，以在这个诊断成像多模态方法的时代优化成像方式的成本效益。
